Salute e Benessere
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
Please find below a statement of such trading in shares issued by Novo Nordisk (see pdf-file for proper format).
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name of the Board member/Executive/Associated Person
Novo Holdings A/S, associated to Kasim Kutay
2
Reason for the notification
a)
Position/status
Member of the Board of Directors
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer
a)
Name
Novo Nordisk A/S
b)
LEI
549300DAQ1CVT6CXN342
4
Details of the transaction(s)
a)
Description of the financial instrument, type of instrument,
Identification code
Shares
Novo Nordisk B DK0062498333
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
d)
Aggregated information
6,311,250 shares
DKK 4,736,088,225.00
e)
Date of the transaction
2024-11-08
f)
Place of the transaction
Outside a trading venue
Contacts for further information
Company announcement No 86 / 2024
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti